Benign Pediatric Jaw Lesions at Massachusetts General Hospital Over 13 Years

Abstract Purpose No study has reported pediatric jaw lesions according to the latest WHO classification of Head and Neck Tumors. We aim to review the spectrum of benign pediatric jaw lesions treated at Massachusetts General Hospital over a 13-year period according to the 2017 WHO Classification. Methods The investigators implemented a retrospective cohort study composed of patients Results The sample consisted of 131 patients(58 males and 73 females with a mean age of 12.6±3.7 years) with 14 pathologic diagnoses, grouped as follows: non-OT(n=67), OT(n=36), and well-circumscribed compared to OT and non-OT(P Conclusion Although pediatric jaw lesions are uncommon, symptoms such as swelling may indicate potential pathology and require panoramic examination. Management of pediatric jaw lesions should take the biologic behavior of the lesion, maxillofacial development and growth into consideration. Enucleation in combination with pharmacologic therapy is a promising strategy for the management of aggressive central giant cell tumors in children.